Prostate cancer as a model for tumour immunotherapy. Jul 2010 - Nat. Rev. Immunol.; 10(8):1474-1741 [PMID:20651745] [Drake CG]
Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model. Apr 2010 - :1550-6606 [PMID:20427765] [Higham EM] [Shen CH] [Wittrup KD] [Chen J]
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer. Mar 2010 - Cancer Treat. Rev.; 36(2):1532-1967 [PMID:19954892] [Matera L]
Current status of immunological therapies for prostate cancer. Feb 2010 - :1473-6586 [PMID:20179598] [Antonarakis ES] [Drake CG]
A changing world for DCvax: a PSMA loaded autologous dendritic cell vaccine for prostate cancer. Nov 2009 - Expert Opin Biol Ther; 9(12):1744-7682 [PMID:19916735] [Fishman M]
Oncolytic virus therapy for prostate cancer. Oct 2009 - Int. J. Urol.:1442-2042 [PMID:19832925] [Fukuhara H] [Homma Y] [Todo T]
Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer. May 2009 - Prostate; 69(9):1097-0045 [PMID:19267351] [Kim S] [Lee JB] [Lee GK] [Chang J]
Tumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens. Apr 2009 - Urol. Oncol.:1873-2496 [PMID:19362861] [Turkeri L] [Onol FF] [Ozyurek M]
FOCUS on FOCIS: combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer. Apr 2009 - Clin. Immunol.; 131(1):1521-7035 [PMID:19201656] [Rozková D] [Tiserová H] [Fucíková J] [Last'ovicka J] [Podrazil M] [Ulcová H] [Budínský V] [Prausová J] [Linke Z] [Minárik I] [Sedivá A] [Spísek R] [Bartůnková J]
Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization. Mar 2009 - Prostate; 69(6):1097-0045 [PMID:19143030] [Koh YT] [Gray A] [Higgins SA] [Hubby B] [Kast WM]
Promising novel immunotherapies and combinations for prostate cancer. Mar 2009 - ; 5(2):1744-8301 [PMID:19284377] [Arlen PM] [Mohebtash M] [Madan RA] [Gulley JL]
Dendritic cells transduced with a PSMA-encoding adenovirus and cocultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against prostate cancer cells. Dec 2008 - Urol. Oncol.; 27(1):1078-1439 [PMID:18367124] [Wang K] [Gao X] [Pang J] [Liu X] [Cai Y] [Zhang Y] [Zhou J] [Zhan H]
Dendritic cell vaccines for the treatment of prostate cancer. Nov 2008 - Urol. Oncol.; 26(6):1078-1439 [PMID:18996314] [Lehrfeld TJ] [Lee DI]
A two-state cell damage model under hyperthermic conditions: theory and in vitro experiments. Jul 2008 - J Biomech Eng; 130(4):0148-0731 [PMID:18601458] [Feng Y] [Tinsley Oden J] [Rylander MN]
Immunotherapy for metastatic prostate cancer. Jul 2008 - Urol. Oncol.; 26(4):1078-1439 [PMID:18593624] [Drake CG]
